Direto do fabricanteFabricante de ingredientes naturais

ISO9001ISO22000FDAHalalCertificação GMP30+ países

D-manose em pó

Product Name:d-manose

Grade:qualidade alimentar

Appearance:Pó branco

Assay:99% d-mannose

Test:HPLC UV

Place of Origin:Shaanxi,China

CAS No.:3458-28-4

Brand Name:Erva pura

Active Ingredient:d-manose

Sample:d-manose disponível

Storage:Lugar fresco e seco

Shelf Life:2 years

Consulta de produto

Core Advantages of D-Mannose Powder:

  • Defesa de Precisão para a Saúde Urinária Targeted Anti-Adhesion: Competitively binds to the FimH flagella of Escherichia coli (with an affinity 50 times that of glucose), blocking bacterial adhesion to the urinary tract, with a bacterial clearance rate of over 90% within 24 hours Non-antibiotic mechanism: Does not kill bacteria, avoiding antibiotic resistance and disruption of the intestinal microbiota
  • Vantagens metabólicas e de segurança Smart Excretion: 85% of the original form is excreted via urine after oral administration, with local urinary system concentrations reaching 100 times that of blood Zero Glycemic Burden: Glycemic Index (GI) is only 2 (glucose is 100), safe for diabetic patients
  • Tecnologia de formulação sinérgica Cranberry synergistic effect: Proanthocyanidins inhibit bacterial biofilms, enhancing efficacy by 2 times Probiotic enhancement: Combined with Lactobacillus to reduce infection recurrence rate by 50%
  • Conveniência de uso Instant micro powder: Dissolves in cold water in 3 seconds, with natural sweetness (50% of sucrose sweetness) Extreme safety: Acute toxicity LD50 > 10 g/kg, safe for use by pregnant women and children

Functional Effects of D-Mannose:

  • ✅ Urinary Tract Infection (UTI) Management Acute episodes: 85% symptom relief rate within 48 hours Recurrence prevention: 1g/day taken before bedtime reduces annual recurrence rate from 5-6 times to 0-1 times
  • ✅ Saúde Ginecológica Adjuvant treatment for bacterial vaginosis, improvement of postmenopausal urinary syndrome.
  • ✅ Proteção pós-operatória Reduces the risk of catheter-associated urinary tract infections by 70%, and reduces calcium oxalate crystals in urine by 25% in patients with kidney stones
  • ✅ Sinergia intestino-urinária Promotes the proliferation of bifidobacteria , inhibits the migration of pathogenic bacteria, and reduces endotoxin entry into the bloodstream。

Consulta de produto

WhatsApp +86-17782867973